Barclays’s Curis CRIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.64K | Buy |
+349
| New | +$3.58K | ﹤0.01% | 4810 |
|
|
2025
Q4 | – | Hold |
0
| – | -$2 | – | 5321 |
|
|
2025
Q3 | – | Hold |
0
| – | – | – | 5431 |
|
|
2025
Q2 | – | Hold |
0
| – | – | – | 5184 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 5212 |
|
|
2023
Q3 | – | Sell |
-750
| Closed | -$249K | – | 4617 |
|
|
2023
Q2 | $249K | Hold |
750
| – | – | ﹤0.01% | 3141 |
|
|
2023
Q1 | $179K | Hold |
750
| – | – | ﹤0.01% | 3858 |
|
|
2022
Q4 | $165K | Hold |
750
| – | – | ﹤0.01% | 3957 |
|
|
2022
Q3 | $210K | Hold |
750
| – | – | ﹤0.01% | 3170 |
|
|
2022
Q2 | $295K | Sell |
750
-36
| -5% | -$15K | ﹤0.01% | 3204 |
|
|
2022
Q1 | $749K | Buy |
786
+23
| +3% | +$29.4K | ﹤0.01% | 2614 |
|
|
2021
Q4 | $1.45M | Buy |
763
+360
| +89% | +$856K | ﹤0.01% | 2582 |
|
|
2021
Q3 | $1.26M | Buy |
403
+18
| +5% | +$56.2K | ﹤0.01% | 2643 |
|
|
2021
Q2 | $1.24M | Buy |
385
+202
| +110% | +$913K | ﹤0.01% | 2514 |
|
|
2021
Q1 | $830K | Buy |
183
+101
| +123% | +$422K | ﹤0.01% | 2884 |
|
|
2020
Q4 | $268K | Buy |
+82
| New | +$98.5K | ﹤0.01% | 3597 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 5266 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 5660 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6179 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6404 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6760 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6972 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 7047 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6986 |
|
|
2018
Q3 | – | Sell |
-99
| Closed | -$64.5K | – | 7156 |
|
|
2018
Q2 | $68K | Buy |
99
+84
| +560% | +$86.1K | ﹤0.01% | 5470 |
|
|
2018
Q1 | $19K | Sell |
15
-3
| -17% | -$3.93K | ﹤0.01% | 6446 |
|
|
2017
Q4 | $25K | Buy |
18
+14
| +350% | +$32.9K | ﹤0.01% | 6170 |
|
|
2017
Q3 | $13K | Buy |
4
+3
| +300% | +$11.1K | ﹤0.01% | 5993 |
|
|
2017
Q2 | $4K | Sell |
1
-1
| -50% | -$4.18K | ﹤0.01% | 6267 |
|
|
2017
Q1 | $8K | Sell |
2
-3
| -60% | -$16.7K | ﹤0.01% | 6133 |
|
|
2016
Q4 | $29K | Buy |
+5
| New | +$30K | ﹤0.01% | 5449 |
|
|
2016
Q3 | – | Sell |
-32
| Closed | -$117K | – | 6218 |
|
|
2016
Q2 | $100K | Buy |
+32
| New | +$114K | ﹤0.01% | 4400 |
|
|
2016
Q1 | – | Sell |
-1
| Closed | -$3.37K | – | 5952 |
|
|
2015
Q4 | $5K | Buy |
+1
| New | +$4.88K | ﹤0.01% | 5565 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$5.66K | – | 6514 |
|
|
2015
Q2 | $6K | Buy |
+1
| New | +$6.01K | ﹤0.01% | 6340 |
|
|
2015
Q1 | – | Sell |
-5
| Closed | -$24.1K | – | 7091 |
|
|
2014
Q4 | $9K | Sell |
5
-2
| -29% | -$5.26K | ﹤0.01% | 6776 |
|
|
2014
Q3 | $14K | Sell |
7
-22
| -76% | -$74K | ﹤0.01% | 6688 |
|
|
2014
Q2 | $60K | Buy |
29
+19
| +190% | +$77.4K | ﹤0.01% | 5805 |
|
|
2014
Q1 | $39K | Sell |
10
-80
| -89% | -$481K | ﹤0.01% | 6185 |
|
|
2013
Q4 | $357K | Buy |
90
+88
| +4,400% | +$603K | ﹤0.01% | 4420 |
|
|
2013
Q3 | $17K | Sell |
2
-4
| -67% | -$32.3K | ﹤0.01% | 6578 |
|
|
2013
Q2 | $39K | Buy |
+6
| New | +$42.4K | ﹤0.01% | 6470 |
|
Other funds holding CRIS
BL
SCM
SFM
NCM
CCC
CM
MCM
Barclays's CRIS Position: Q2 2026 in Review
Barclays opened a new position in Curis (CRIS) in Q2 2026: 349 shares worth $3.64K. The stake represents ﹤0.01% of the portfolio and ranks #4810 among its holdings. This is a return to the name: Barclays previously reported a position in CRIS as recently as Q2 2023.
Barclays first reported a position in CRIS in Q2 2013 and has held it in 29 quarters since. The position peaked at $1.45M in Q4 2021. 34 funds tracked by Wall St. Rank hold CRIS as of Q2 2026.
- Barclays held 349 shares of Curis worth $3.64K as of Q2 2026.
- Curis was a new Barclays position in Q2 2026.
- Curis made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4810 holding.
- Barclays first reported a position in Curis in Q2 2013 and has held it in 29 quarters since.
- Barclays's Curis position peaked at $1.45M in Q4 2021.
- 34 funds tracked by Wall St. Rank held Curis as of Q2 2026.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.